| http://www.w3.org/ns/prov#value | - Other companies including GlaxoSmithKline and Johnson & Johnson have set up similar partnerships and initiatives looking to utilise the wider scientific community in order to develop new treatments.These new methods benefit both parties with the Pharma companies not needing to invest in expensive in-house research and the scientific community gaining access to state of the art equipment and expert
|
